1. Home
  2. SKWD vs KNSA Comparison

SKWD vs KNSA Comparison

Compare SKWD & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKWD
  • KNSA
  • Stock Information
  • Founded
  • SKWD 2007
  • KNSA 2015
  • Country
  • SKWD United States
  • KNSA United Kingdom
  • Employees
  • SKWD N/A
  • KNSA N/A
  • Industry
  • SKWD Property-Casualty Insurers
  • KNSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SKWD Finance
  • KNSA Health Care
  • Exchange
  • SKWD Nasdaq
  • KNSA Nasdaq
  • Market Cap
  • SKWD 2.3B
  • KNSA 2.6B
  • IPO Year
  • SKWD 2023
  • KNSA 2018
  • Fundamental
  • Price
  • SKWD $48.03
  • KNSA $38.30
  • Analyst Decision
  • SKWD Buy
  • KNSA Strong Buy
  • Analyst Count
  • SKWD 13
  • KNSA 7
  • Target Price
  • SKWD $62.64
  • KNSA $44.00
  • AVG Volume (30 Days)
  • SKWD 541.0K
  • KNSA 403.5K
  • Earning Date
  • SKWD 10-28-2025
  • KNSA 10-28-2025
  • Dividend Yield
  • SKWD N/A
  • KNSA N/A
  • EPS Growth
  • SKWD 6.84
  • KNSA N/A
  • EPS
  • SKWD 3.16
  • KNSA 0.07
  • Revenue
  • SKWD $1,253,720,000.00
  • KNSA $529,332,000.00
  • Revenue This Year
  • SKWD $17.72
  • KNSA $37.21
  • Revenue Next Year
  • SKWD $15.95
  • KNSA $12.07
  • P/E Ratio
  • SKWD $15.25
  • KNSA $577.26
  • Revenue Growth
  • SKWD 21.67
  • KNSA 56.18
  • 52 Week Low
  • SKWD $41.28
  • KNSA $17.82
  • 52 Week High
  • SKWD $65.05
  • KNSA $39.12
  • Technical
  • Relative Strength Index (RSI)
  • SKWD 50.84
  • KNSA 63.72
  • Support Level
  • SKWD $44.09
  • KNSA $37.35
  • Resistance Level
  • SKWD $47.68
  • KNSA $38.83
  • Average True Range (ATR)
  • SKWD 1.28
  • KNSA 0.97
  • MACD
  • SKWD 0.20
  • KNSA 0.03
  • Stochastic Oscillator
  • SKWD 90.00
  • KNSA 76.50

About SKWD Skyward Specialty Insurance Group Inc.

Skyward Specialty Insurance Group Inc is a specialty insurance company that delivers commercial property and casualty products and solutions on a non-admitted and admitted basis. The firm has one reportable segment through which it offers a broad array of insurance coverages to several market niches. It operates multiple lines of business, including general liability, excess liability, professional liability, commercial auto, group accident, health, property, surety, and workers' compensation.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Share on Social Networks: